Seattle Children’s is working in partnership with Fred Hutchinson Cancer Research Center, UW Medicine and Seattle Cancer Care Alliance (SCCA) to explore restructuring our longtime relationship to accelerate our shared mission of advancing diagnosis, treatment and pioneering of cures for cancer and other diseases. If the proposed restructure is finalized and approved, it will establish an adult-focused oncology program and a separate pediatric oncology program that operate collaboratively and will integrate the innovative cancer research from Fred Hutch, UW Medicine and Seattle Children’s.
The restructure envisions that SCCA and Fred Hutch would merge to form Fred Hutchinson Cancer Center (FHCC). FHCC would operate as a clinically integrated part of UW Medicine. Seattle Children’s would continue operating independently and be the central site for pediatric cancer care among the organizations. The outpatient pediatric bone marrow transplant program at SCCA would be consolidated at Seattle Children’s as part of the hospital’s upcoming expansion with the opening of the new Building Care on the main campus.
For more information, read Seattle Children’s press release and The Seattle Times, “Seattle cancer programs to pursue new partnership, to form Fred Hutch Cancer Center,” July 13, 2021.
